Try our Advanced Search for more refined results
Abraxis BioScience Inc.
-
Filed: July 25, 2023 | Entered: July 25, 2023 Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
835(Patent - Abbreviated New Drug Applications (ANDA)) | West Virginia Northern
Consent Judgment
CONSENT JUDGMENT in favor of Abraxis Bioscience, LLC against Mylan Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 7/25/2023. (hrc) (Entered: 07/25/2023)
-
Filed: July 24, 2023 | Entered: July 24, 2023 Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
835(Patent - Abbreviated New Drug Applications (ANDA)) | West Virginia Northern
Proposed Consent Judgment Order by Abraxis Bioscience, LLC. (Taylor, Chad) (Entered: 07/24/2023)
-
Filed: June 30, 2023 | Entered: June 30, 2023 Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
835(Patent - Abbreviated New Drug Applications (ANDA)) | West Virginia Northern
Certificate Of Service
CERTIFICATE OF SERVICE by Abraxis Bioscience, LLC for its Initial Infringement Contentions. (Taylor, Chad) (Entered: 06/30/2023)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login